Processa Pharmaceuticals, Inc.

( )
PCSA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Producer Manufacturing » Industrial Machinery
AMATApplied Materials, Inc. 4.92%80.501.5%$671.44m
ASMLASML Holding NV 0.84%427.150.7%$384.82m
PHParker-Hannifin Corp. 1.72%271.712.2%$297.50m
CARRCarrier Global Corp. 0.65%38.790.0%$243.61m
ITWIllinois Tool Works, Inc. 2.48%208.892.3%$222.38m
MIDDThe Middleby Corp. 1.28%137.015.6%$106.45m
IRIngersoll Rand, Inc. 0.50%44.480.9%$104.49m
IEXIDEX Corp. -0.45%193.102.2%$101.68m
DOVDover Corp. -0.05%123.421.3%$97.03m
GTECGreenland Technologies Holding Corp. 64.18%7.700.0%$79.04m
XYLXylem, Inc. 0.39%94.752.8%$78.59m
NNDMNano Dimension Ltd. 16.93%5.180.0%$78.31m
WWDWoodward, Inc. 3.09%112.002.0%$44.75m
CFXColfax Corp. 3.41%36.682.3%$43.47m
GGGGraco, Inc. 0.37%68.371.5%$43.27m

Company Profile

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.